These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28871238)

  • 21. Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study.
    Saposnik G; Andhavarapu S; Fernández Ó; Kim HJ; Wiendl H; Foss M; Zuo F; Havrdová EK; Celius E; Caceres F; Magyari M; Bermel R; Costa A; Terzaghi M; Kalincik T; Popescu V; Amato MP; Montalban X; Oh J
    Mult Scler Relat Disord; 2022 Feb; 58():103404. PubMed ID: 35216786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herding: a new phenomenon affecting medical decision-making in multiple sclerosis care? Lessons learned from DIScUTIR MS.
    Saposnik G; Maurino J; Sempere AP; Ruff CC; Tobler PN
    Patient Prefer Adherence; 2017; 11():175-180. PubMed ID: 28203061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimedia educational interventions for consumers about prescribed and over-the-counter medications.
    Ciciriello S; Johnston RV; Osborne RH; Wicks I; deKroo T; Clerehan R; O'Neill C; Buchbinder R
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008416. PubMed ID: 23633355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teriflunomide for multiple sclerosis.
    He D; Zhang C; Zhao X; Zhang Y; Dai Q; Li Y; Chu L
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009882. PubMed ID: 27003123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a multimedia website with patient experiences of multiple sclerosis (PExMS) on immunotherapy decision-making: study protocol for a pilot randomised controlled trial in a mixed-methods design.
    Barabasch A; Riemann-Lorenz K; Kofahl C; Scheiderbauer J; Eklund D; Kleiter I; Kasper J; Köpke S; Lezius S; Zapf A; Rahn AC; Heesen C
    Pilot Feasibility Stud; 2021 Jan; 7(1):16. PubMed ID: 33413658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-consultation educational group intervention to improve shared decision-making for postmastectomy breast reconstruction: a pilot randomized controlled trial.
    Causarano N; Platt J; Baxter NN; Bagher S; Jones JM; Metcalfe KA; Hofer SO; O'Neill AC; Cheng T; Starenkyj E; Zhong T
    Support Care Cancer; 2015 May; 23(5):1365-75. PubMed ID: 25351455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trial.
    Wahls T; Scott MO; Alshare Z; Rubenstein L; Darling W; Carr L; Smith K; Chenard CA; LaRocca N; Snetselaar L
    Trials; 2018 Jun; 19(1):309. PubMed ID: 29866196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. e-Therapy to reduce emotional distress in women undergoing assisted reproductive technology (ART): a feasibility randomized controlled trial.
    van Dongen AJ; Nelen WL; IntHout J; Kremer JA; Verhaak CM
    Hum Reprod; 2016 May; 31(5):1046-57. PubMed ID: 26965429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-week inpatient energy management education (IEME) for persons with multiple sclerosis-related fatigue: Feasibility of a randomized clinical trial.
    Hersche R; Weise A; Michel G; Kesselring J; Bella SD; Barbero M; Kool J
    Mult Scler Relat Disord; 2019 Oct; 35():26-33. PubMed ID: 31280074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
    Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
    Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial.
    Martin P; Tamblyn R; Benedetti A; Ahmed S; Tannenbaum C
    JAMA; 2018 Nov; 320(18):1889-1898. PubMed ID: 30422193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Computer-Based Substance Use Screening and Brief Behavioral Counseling vs Usual Care for Youths in Pediatric Primary Care: A Pilot Randomized Clinical Trial.
    Knight JR; Sherritt L; Gibson EB; Levinson JA; Grubb LK; Samuels RC; Silva T; Vernacchio L; Wornham W; Harris SK
    JAMA Netw Open; 2019 Jun; 2(6):e196258. PubMed ID: 31225897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab for relapsing-remitting multiple sclerosis.
    He D; Guo R; Zhang F; Zhang C; Dong S; Zhou H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009130. PubMed ID: 24310855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial.
    Cohen JA; Comi G; Selmaj KW; Bar-Or A; Arnold DL; Steinman L; Hartung HP; Montalban X; Kubala Havrdová E; Cree BAC; Sheffield JK; Minton N; Raghupathi K; Huang V; Kappos L;
    Lancet Neurol; 2019 Nov; 18(11):1021-1033. PubMed ID: 31492652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of a strategy that uses educational games to implement clinical practice guidelines among Spanish residents of family and community medicine (e-EDUCAGUIA project): a clinical trial by clusters.
    Del Cura-González I; López-Rodríguez JA; Sanz-Cuesta T; Rodríguez-Barrientos R; Martín-Fernández J; Ariza-Cardiel G; Polentinos-Castro E; Román-Crespo B; Escortell-Mayor E; Rico-Blázquez M; Hernández-Santiago V; Azcoaga-Lorenzo A; Ojeda-Ruiz E; González-González AI; Ávila-Tomas JF; Barrio-Cortés J; Molero-García JM; Ferrer-Peña R; Tello-Bernabé ME; Trujillo-Martín M;
    Implement Sci; 2016 May; 11():71. PubMed ID: 27189180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Decisions in Atrial Fibrillation for Stroke Prevention: The Role of Aversion to Ambiguity and Physicians' Risk Preferences.
    Sposato LA; Stirling D; Saposnik G
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2088-2095. PubMed ID: 29650382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological management of multiple sclerosis: evaluation of a supervised and customized cognitive rehabilitation program for self-used at home (SEPIA): protocol for a randomized controlled trial.
    Harand C; Daniel F; Mondou A; Chevanne D; Creveuil C; Defer G
    Trials; 2019 Oct; 20(1):614. PubMed ID: 31665039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial.
    Rahn AC; Köpke S; Kasper J; Vettorazzi E; Mühlhauser I; Heesen C
    Trials; 2015 Mar; 16():106. PubMed ID: 25872529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision making under uncertainty in the diagnosis and management of Alzheimer's Disease in primary care: A study protocol applying concepts from neuroeconomics.
    Saposnik G; Ismail Z; Rivard AM; Knifton D; Bromfield G; Terzaghi M; Montoya A; Menard MC
    Front Med (Lausanne); 2022; 9():997277. PubMed ID: 36330061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.